Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Roche Products Pty Limited

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Designation or determination (21)
Australian Public Assessment Report (AusPAR) (11)
Prescription medicine decision summary (5)
Prescription medicine registration (2)

Date

2023 (3)
2022 (2)
2021 (7)
2020 (9)
2019 (6)
2018 (6)
2017 (4)
2016 (1)
2014 (1)

Results for "[search-keyword]"

Search

Sponsor content

39 result(s) found, displaying 21 to 30

Notice for atezolizumab (Roche Products Pty Limited)

10 January 2020

Designation or determination

Orphan drug
Polivy

13 December 2019

Prescription medicine decision summary

Australian prescription medicine decision summary
Notice for satralizumab (Roche Products Pty Limited)

12 September 2019

Designation or determination

Orphan drug
Notice for atezolizumab (Roche Products Pty Limited)

5 June 2019

Designation or determination

Provisional approval
Notice for entrectinib (Roche Products Pty Limited)

17 April 2019

Designation or determination

Provisional approval
Notice for trastuzumab emtansine (Roche Products Pty Limited)

5 March 2019

Designation or determination

Priority review
Notice for polatuzumab vedotin (Roche Products Pty Limited)

21 January 2019

Designation or determination

Priority review
Notice for atezolizumab (Roche Products Pty Limited)

27 September 2018

Designation or determination

Orphan drug
AusPAR: Ocrelizumab

8 August 2018

Australian Public Assessment Report (AusPAR)

Australian Public Assessment Report for Ocrelizumab
AusPAR: Tocilizumab (rch)

4 June 2018

Australian Public Assessment Report (AusPAR)

Australian Public Assessment Report for Tocilizumab (rch)

Pages

First page
Previous page
Page 1
Page 2
Current page 3
Page 4
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.